Try our Advanced Search for more refined results
Searching dockets in Prometheus Laboratories 1 x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Personal Inj. Med. Malpractice | California Northern
Clerk's Notice
CLERK'S NOTICE re remand. (far, COURT STAFF) (Filed on 8/14/2024)
Motion Hearing Order on Motion to Remand Order on Motion to Dismiss
Minute Entry for proceedings held before Judge P. Casey Pitts: Motion Hearing held on 8/8/2024. re 18 MOTION to Remand filed by Nguyen Dat Le, 27 MOTION to Dismiss PLAINTIFFS FIRST AMENDED COMPLAINT filed by Casper Pharma LLC.
For the reasons stated on the record, 18 Motion to Remand is granted and the action is hereby remanded to the Santa Clara County Superior Court. For the reasons stated on the record, 27 Motion to Dismiss is denied without prejudice. No Further Order to Issue.
Plaintiff Attorney: Kenneth Melrose. Defendant Attorney: Mike Hurvitz for Casper Pharma, Inc. Alexis Buese for Prometheus Laboratories, Inc.
Total Time in Court: 32 min. (10:00-10:32 am). Court Reporter: Lee-Anne Shortridge.
(This is a text-only entry generated by the court. There is no document associated with this entry.) (sfb, COURT STAFF) (Date Filed: 8/8/2024)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.